我要投票 百灵鸟在中草药行业中的票数:1132
· 外 推 电 报 ·
2025-09-21 19:42:30 星期日

【百灵鸟是哪个国家的品牌?】

百灵鸟是什么牌子?「百灵鸟」是 贵州百灵企业集团制药股份有限公司 旗下著名品牌。该品牌发源于贵州,由创始人姜伟在1999期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力百灵鸟品牌出海!将品牌入驻外推网,定制百灵鸟品牌推广信息,可以显著提高百灵鸟产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

贵州百灵企业集团于2005年5月组建,现有总资产28亿元。其核心企业(母公司)是贵州百灵企业集团制药股份有限公司(深交所002424),成员包括:贵州百灵企业集团天台山药业有限公司、贵州百灵企业集团医药销售有限公司、贵州百灵企业集团纯净水有限公司、贵州百灵企业集团乾元制药有限公司、贵州百灵企业集团千禧制药有限公司,河北德信润生制药有限公司。
2010年,贵州百灵实现主营业务收入8.67亿元,上缴各项税金1.6亿元,总资产28亿元,员工2100余人。
特色就是品牌内涵,特色就是核心竞争力。贵州百灵立足产品的民族化特色,博采民族医药之众长,以科技创新深度研发为突破,走产业化、规模化的品牌发展道路,现已形成“百灵鸟”牌咳速停糖浆(及胶囊)、银丹心脑通软胶囊、维C银翘片、金感胶囊为主导的强势产品架构,涵盖片剂、胶囊剂、糖浆剂等12种生产剂型,107个药品生产批文,多样化、可持续化的品牌体系日臻完善。贵州百灵的产品经多年医学临床运用,其疗效确切、安全、优质、平价等特点为广大患者、业界、市场广泛认同和赞誉。贵州百灵现已成为国内苗药龙头企业之一。
2010年2月26日,中国证监会发审委审核通过了贵州百灵的上市首发申请,并于6月3日在深圳证券交易所正式挂牌上市。贵州百灵在历经两年半的努力后取得这一重大突破,为贵州百灵借助资本市场的强大动力加快发展奠定了坚实的基础。
用心经营健康、用爱回报社会。多年来,贵州百灵积极履行各项社会责任,为社会各界捐款捐物2000余万元。关注健康、服务社会的企业精神深入人心,集成企业发展的巨大内在动力。
贵州百灵长期致力于宣传贵州,以弘扬民族医药事业为己任,积极寻求企业文化创建的方式和载体,出资赞助贵州百灵围棋队、贵州百灵拉力赛车队、贵州百灵少年围棋队,通过参与多项全国赛事,先后取得全国围棋团体赛冠军、全国汽车拉力锦标赛总冠军等多项殊荣。
壁立千仞造就高贵品质,海纳百川始成大家气象。让特色更特,让优势更优,让深度更深,是贵州百灵追求不断超越的灵魂。面对未来,千帆竞渡百舸争流,在新的竞争平台上贵州百灵清醒地认识自己,不断努力进取、开拓创新,以更加积极向上的姿态向全国民族药主导企业的目标奋力前进。

英文翻译:Guizhou bailing enterprise group was established in May 2005 with total assets of 2.8 billion yuan. Its core enterprise (parent company) is Guizhou bailing Group Pharmaceutical Co., Ltd. (Shenzhen Stock Exchange 002424). Its members include: Guizhou bailing group Tiantaishan Pharmaceutical Co., Ltd., Guizhou bailing Group Pharmaceutical Sales Co., Ltd., Guizhou bailing group pure water Co., Ltd., Guizhou bailing group Qianyuan Pharmaceutical Co., Ltd. and Guizhou bailing group Millennium system Pharmaceutical Co., Ltd., Hebei Dexin Runsheng Pharmaceutical Co., Ltd. In 2010, Guizhou bailing achieved a main business income of 867 million yuan, taxes of 160 million yuan, total assets of 2.8 billion yuan, and more than 2100 employees. Characteristic is the connotation of brand, and characteristic is the core competitiveness. Guizhou bailing, based on the national characteristics of its products, has taken the advantages of national medicine, made a breakthrough in scientific and technological innovation and developed its brand in an industrialized and large-scale way. Now it has formed a strong product structure dominated by "bailingniao" brand keshiding syrup (and capsule), Yindanxinnaotong soft capsule, Weic Yinqiao tablet and Jingan capsule, covering tablet, capsule and syrup With 12 kinds of production dosage forms and 107 drug production approvals, the diversified and sustainable brand system is becoming more and more perfect. Guizhou bailing's products have been used in clinical medicine for many years, and its efficacy is accurate, safe, high-quality, affordable and other characteristics are widely recognized and praised by patients, industry and market. Guizhou bailing has become one of the leading seedling medicine enterprises in China. On February 26, 2010, the development and Audit Committee of CSRC approved the IPO application of Guizhou bailing, and it was officially listed on Shenzhen Stock Exchange on June 3. After two and a half years of efforts, Guizhou bailing has made this major breakthrough, which has laid a solid foundation for Guizhou bailing to speed up its development with the help of the powerful power of the capital market. Manage health with heart and repay society with love. Over the years, Guizhou bailing has actively fulfilled various social responsibilities and donated more than 20 million yuan to all sectors of society. The enterprise spirit of paying attention to health and serving the society is deeply rooted in the people's mind, integrating the huge internal power of enterprise development. Guizhou bailing has been committed to promoting Guizhou for a long time, taking the promotion of national medicine as its own duty, actively seeking the way and carrier of corporate culture creation, funding and sponsoring Guizhou bailing go team, Guizhou bailing Rally Team, Guizhou bailing juvenile go team. Through participating in a number of national events, Guizhou Bailing has successively won the national go team championship, the national automobile rally championship championship and many other titles Honor. The noble quality is created by standing on the wall and embracing all rivers. It is the soul that Guizhou bailing pursues to surpass constantly to make its features more special, advantages better and depth deeper. In the face of the future, Qianfan is competing for the best. On the new competition platform, Guizhou bailing has a clear understanding of itself, and constantly strives to forge ahead, develop and innovate, so as to strive forward to the goal of leading national medicine enterprises with a more positive attitude.

本文链接: https://www.waitui.com/brand/2d716e852.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

山西汾酒:股东华创鑫睿计划减持不超1.33%公司股份

36氪获悉,山西汾酒发布公告,根据联和基金相关合作协议,其面临基金到期退出安排,需要减持其间接持有的全部公司股份,因此持股5%以上股东华创鑫睿本次拟通过大宗交易方式减持不超过1620.06万股(含本数),计划减持比例不超过1.33%;自本次减持计划公开披露之日起15个交易日后的3个月内(含3个月期满当日)实施。

2小时前

中信证券:三方面的技术趋势将推动刻蚀设备的用量和重要性提升

36氪获悉,中信证券预计,至少以下三方面的技术趋势将推动刻蚀设备的用量和重要性提升:1.光刻多重图案化路线的采用;2.三维堆叠存储和近存计算需求;3.底层晶体管结构升级。长期看,半导体设备国产化方向明确,短期来看,下游扩产有望驱动行业进入新一轮增长期。建议关注国内刻蚀设备厂商以及相关配套设备、零部件企业机会。

2小时前

中信证券:右侧趋势品种继续聚焦资源、消费电子、创新药和游戏

36氪获悉,中信证券研报表示,目前整体的行业选择框架依然是围绕资源+新质生产力+出海。资源股在供给受限以及全球地缘动荡的预期推动下,从周期属性转向偏红利属性会带来估值体系重构,博弈美联储降息的资金退潮带来的波动可以忽略。更大的中期线索还是中国制造业龙头的全球化,将份额优势转化为定价权和利润率提升,带来超越本国经济基本面的市值增长,从而逐步打破行情与基本面背离且全靠流动性驱动的错误认知。配置结构上,保持定力,右侧趋势品种继续聚焦资源、消费电子、创新药和游戏;左侧配置关注化工和军工;产业趋势层面,近期重点关注AI从云侧逻辑开始向端侧逻辑扩散。

2小时前

环球印务:股东香港原石拟减持不超1%公司股份

36氪获悉,环球印务发布公告,持股10.98%的股份的股东香港原石国际有限公司(简称“香港原石”)计划以集中竞价交易合计减持不超过320.04万股公司股份,占公司总股本比例的1%。

2小时前

冠中生态:筹划控制权变更事项,股票停牌

36氪获悉,冠中生态发布公告,公司控股股东青岛冠中投资集团有限公司及实际控制人李春林和许剑平正在筹划公司控制权变更相关事宜,可能导致公司控股股东及实际控制人发生变更。经申请,公司股票及可转换公司债券自2025年9月22日起停牌,预计停牌时间不超过2个交易日。停牌期间,公司可转换公司债券“冠中转债”将暂停转股。

2小时前

本页详细列出关于百灵鸟的品牌信息,含品牌所属公司介绍,百灵鸟所处行业的品牌地位及优势。
咨询